Skip to main content
Top
Published in: Hormones 2/2016

01-04-2016 | Review

Cardiovascular safety of type 2 diabetes medications: Review of existing literature and clinical implications

Authors: Sílvia Paredes, Claudia Matta-Coelho, Ana Margarida Monteiro, Alice Brás, Olinda Marques, Marta Alves, Laura Ribeiro, PhD

Published in: Hormones | Issue 2/2016

Login to get access
Metadata
Title
Cardiovascular safety of type 2 diabetes medications: Review of existing literature and clinical implications
Authors
Sílvia Paredes
Claudia Matta-Coelho
Ana Margarida Monteiro
Alice Brás
Olinda Marques
Marta Alves
Laura Ribeiro, PhD
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
Hormones / Issue 2/2016
Print ISSN: 1109-3099
Electronic ISSN: 2520-8721
DOI
https://doi.org/10.14310/horm.2002.1671

Other articles of this Issue 2/2016

Hormones 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine